Background: Chitotriosidase (chitinase 1, Chit1), a major true chitinase in humans, is
studies have demonstrated that exaggerated type 2 immune responses play an important role in disease pathogenesis. 3 However, the processes that control type 2 responses in normal airways and how these control mechanisms fail to function in asthma have not been adequately defined.
The 18 glycosyl hydrolase gene family contains true chitinases and chitinase-like proteins (CLP) that bind but do not cleave chitin.
The former includes moieties such as acidic mammalian chitinase (AMCase) and chitotriosidase (chitinase 1; Chit1), which play important roles in the control of chitin-containing pathogens. 4 The latter includes the prototypic CLP, chitinase 3-like-1 (Chi3L1) (BRP-39 in mice and YKL-40 in man), which is an impressive regulator of cell survival, inflammation, and remodeling. 4 Recent studies have demonstrated that AMCase and Chit1 play important roles in the regulation and stimulation of Th2 responses. 5, 6 These studies have demonstrated that the levels of Chit1 are increased in asthma and other diseases characterized by inflammation and remodeling and, in some cases, correlate with fungal sensitization. 5, 7, 8 Moreover, studies from our laboratory and others have demonstrated that
Chit1 is the major chitinase in the human lung and that genetic variations in the CHIT1 are associated with the frequency of atopy and atopic biomarkers, including blood eosinophils, serum IgE, and eosinophil cationic protein (ECP). 9, 10 However, the mechanism(s) by 12 Recent studies from our laboratory have demonstrated that Chit1 augments TGF-b1 signaling. 8 However, a relationship between Chit1 and Tregs has not been defined and the role of Chit1 in the generation of Tregs and their ability to control Th2 inflammation has not been defined.
We hypothesized that Chit1 is induced in childhood asthma and allergen-induced airway inflammation mice where it plays an important role in disease promotion by regulating Th2 inflammation. To test this hypothesis, we characterized the levels of Chit1 in sputum for children with asthma and controls. We also compared the adaptive Th2 responses induced after antigen sensitization and challenge in wild-type and Chit1 null mice and the role of Tregs in the differences that were noted.
| ME TH ODS

| Animals
All experiments used 7 to 13-week-old, sex-and age-matched mice, housed under specific pathogen-free conditions.
Chitotriosidase null mutant (Chit1
) and TGF-b1 transgenic (Tg) mice were generated on a C57BL/6 background and maintained as previously described. 
| Single cell isolation and flow cytometry
Lung, spleen, lymph node (LN) and thymus cells were isolated. 14, 15 For intracellular staining, cells were fixed and permeabilized with Foxp3 staining kit (eBioscience, San Diego, CA, USA) or Fix/Perm reagent kit (BD Biosciences). Samples were run on a FACS LSRII flow cytometer (BD Biosciences), and data were analyzed using FlowJo software (Tree Star, Ashland, OR).
| Human subjects
A total of 140 children aged 6. 
| Statistical analyses
Normally distributed data were analyzed using the Student's t test for two groups or ANOVA followed by Tukey test for 3 or more groups. Chi-square test was used with categorical variables. Correlations between Chit1 levels and PC 20 were evaluated using the Pearson test. All statistical analyses were performed using SPSS 20 (version 22.0, IBM Corp, Armonk, NY).
Details on the other methods employed in this study are included in the Appendix S1.
| RESULTS
| Chit1 accumulation in sputum from childhood asthma
Sputum samples were obtained from childhood asthma and compared with similar samples from age-and sex-matched controls. As shown in Table 1 , the blood eosinophil counts, levels of total IgE, and levels of serum ECP were increased in children with asthma compared to controls (P < .001). Importantly, the levels of sputum Chit1 were significantly higher in the asthmatics compared to the controls (1262 AE 69.97 pg/mL vs 1758 AE 129.2 pg/mL, P = .001; Figure 1A ).
| Regulation and accumulation of murine pulmonary Chit1 during aeroallergen challenge
To define the roles of Chit1, we evaluated the regulation and accumulation of pulmonary Chit1 in murine allergic inflammation. Models were utilized that employ the chitin-free aeroallergen, OVA, and HDM which contains chitin. 17 The levels of Chit1 protein and mRNA were significantly increased in the lungs from OVA sensitized and challenged mice compared with controls ( Figure 1B-D) . IHC evaluation demonstrated that airway epithelial and inflammatory cells, especially alveolar macrophages, are the major cells expressing Chit1 in the lungs of aeroallergen challenged mice ( Figure 1E ). These effects were not specific for chitin-free aeroallergens because similar increases in the levels and sites of Chit1 expression were noted in the lungs from the mice sensitized and challenged with HDM ( Figure 1F ). 
| Role of Chit1 effect on the regulatory T cells in the absence of allergen challenge
To further understand the mechanisms that Chit1 uses to regulate Tregs, studies were undertaken to determine whether Chit1 alters and/or Chit1. The addition of TGF-b1 alone led to an increase in Foxp3 conversion. However, Chit1-deficient T cells showed less effective Foxp3 conversion compared with cells from WT mice (Figure 6E) . In these evaluations, the TGF-b1-induced Foxp3 induction was significantly enhanced with the co-treatment with recombinant Chit1 ( Figure 6E ). These data demonstrate that Chit1 effect is notable only in the presence of TGF-b1 for further development of peripheral CD4 + Foxp3 + iTreg cells from na€ ıve T cells.
| Role of Chit1 in the regulation of TGF-bstimulated TGF-b receptor expression and signaling in T cells
Previous studies from our laboratory demonstrated that Chit1 interacts in a synergistic fashion with TGF-b1 to enhance TGF-b receptor expression and Smad phosphorylation and the development of pulmonary fibrosis. 
| DISCUSSION
Although mammals do not have chitin or chitin synthase, they contain chitinases and CLP that can be detected in the circulation as well as in local tissues. 4, 18, 19 Chit1, a major enzymatically active true chitinase, is produced, stored, and secreted by macrophages and neutrophils and plays important roles in innate immune homeostasis. 20 This can be appreciated in the pivotal roles it plays in host defenses against chitincontaining pathogens such as fungi, protozoa, and insects. 20 Its importance as a sensitive biomarker of macrophage activation can also be seen in its dysregulated expression in a variety of human diseases including Gaucher's disease, diabetes, sarcoidosis, inflammatory bowel disease, atherosclerosis, Alzheimer's disease, and prostate cancer. 21, 22 Recent studies from our laboratory and others have also demonstrated that Chit1 is dysregulated in lung diseases characterized by inflammation and remodeling such as asthma, COPD, and pulmonary fibrosis. 8, 19, 23 However, the roles of Chit1 in these diseases and the mechanisms it uses to contribute to disease pathogenesis have not been defined. To begin to address these deficiencies, we focused on the regulation of Chit1 and its roles in the pathogenesis of allergic asthma. This study demonstrates that Chit1 is expressed in an exaggerated manner in pediatric asthma. Increased expression and activity of Chit1 in patients with asthma was already reported by other studies. 23, 24 Consistent with sputum data from children with asthma, the lung of allergen-induced mice showed a significant increase in the level of Chit1 compared with those of control mice. Chit1 is the most readily active chitinase in the lung from mammal and man 9 and increased in the patients with inflammatory disorder disease also in the animal models. 25, 26 The reasons for the elevation of Chit1 might be associ- Additional investigation will be required to assess the veracity of these speculations and the mechanisms that are involved.
Our studies demonstrate that the levels of TGF-b1 were significantly lower in lungs from allergen sensitized and challenged respectively. [44] [45] [46] [47] In summary, we have shown augmented expression of Chit1 in sputum from patients with asthma compared to healthy subjects. In murine models of asthma-like adaptive Th2 inflammation, these studies demonstrated that Chit1 inhibits aeroallergen-induced Th2 inflammation, IgE production, type 2 cytokine elaboration, and AHR | 1697 responses via regulation of TGF-b expression and its effector function on Tregs.
